Complement and innate immunity

Immunopharmacology

Volumn 49, Issue 1-2, 2000, Pages 187-198

  Song, Wen Chao ^a   Rosa Sarrias, Maria ^a   Lambris, John D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT; REGULATOR PROTEIN;

COMPLEMENT ACTIVATION; CONFERENCE PAPER; HUMAN; IMMUNITY; PRIORITY JOURNAL; REVIEW;

EID: 0343090807     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(00)80303-3     Document Type: Conference Paper

References (115)

1. Ahearn J.M., Fearon D.T. Structure and function of the complement receptors, CR1 (CD35), and CR2 (CD21). Adv. Immunol. 46:1989;183-219.
2. Ahearn J.M., Fischer M.B., Croix D., Goerg S., Ma M., Xia J., Zhou X., Howard R.G., Rothstein T.L., Carroll M.C. Disruption of the Cr2 locus results in a reduction in B-la cells and in an impaired B cell response to T-dependent antigen. Immunity. 4:1996;251-262.
3. Albrecht J.C., Fleckenstein B. McFadden G. Complement Regulatory Proteins of Herpesvirus. 1995;127-145 Saimiri. R.G. Landes, Austin.
4. Al-Sharif W.Z., Sunyer J.O., Lambris J.D., Smith L.C. Sea urchin coelomocytes specifically express a homoloque of the complement component C3. J. Immunol. 160:1997;2983-2997.
5. Atkinson J.P. Complement deficiency. Predisposing factor to autoimmune syndromes. Am. J. Med. 85:1988;45-47.
6. Bendelac A., Fearon D.T. Innate pathways that control acquired immunity. Curr. Opin. Immunol. 9:1997;1-3.
7. Bergelson J.M., Chan M., Solomon K.R., Stjohn N.F., Lin H.M., Finberg R.W. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc. Natl. Acad. Sci. U.S.A. 91:1994;6245-6249.
8. Biron C.A. Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9:1997;24-34.
9. Borregaard N., Elsbach P., Ganz T., Garred P., Svejgaard A. Innate immunity: from plants to humans. Immunol. Today. 21:2000;68-70.
10. Botto M., Dell'Agnola C., Bygrave A.E., Thompson E.M., Cook H.T., Petry F., Loos M., Pandolfi P.P., Walport M.J. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19:1998;56-59.
11. Carroll M.C. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16:1998;545-568.
12. Carroll M.C., Janeway C.A. Innate immunity. Curr. Opin. Immunol. 11:1999;11-12.
13. Carroll M.C., Prodeus A.P. Linkages of innate and adaptive immunity. Curr. Opin. Immunol. 10:1998;36-40.
14. Cervoni P., Oglesby T.J., Fenichel P., Dohr G., Rossi B., Atkinson J.P., Hsi B.L. Expression of decay-accelerating factor (CD55) of the complement system on human spermatozoa. J. Immunol. 151:1993;939-948.
15. Claus D.R., Osmand A.P., Gewurz H. Radioimmunoassay of human C-reactive protein and levels in normal sera. J. Lab. Clin. Med. 87:1976;120-128.
16. Cooper N.R. Complement evasion strategies of microorganisms. Immunol. Today. 12:1991;327-331.
17. Cooper E.L., Rinkevich B., Uhlenbruck G., Valembois P. Invertebrate immunity - another viewpoint - editorial. Scand. J. Immunol. 35:1992;247-266.
18. Daffern P.J., Pfeifer P.H., Ember J.A., Hugli T.E. C3a is a chemotaxin for human eosinophils but not for neutrophils: I. C3a stimulation of neutrophils is secondary to eosinophil activation. J. Exp. Med. 181:1995;2119-2127.
19. Del Rio-Tsonis K., Tsonis P.A., Zarkadis I.K., Tsangas A.G., Lambris J.D. Expression of the third component of complement C3, in regenerating limb blastema cells of urodeles. J. Immunol. 161:1998;6819-6824.
20. Dempsey P.W., Allison M.E.D., Akkaraju S., Goodnow C.C., Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science. 271:1996;348-350.
21. Dunne D.W., Resnick D., Greenberg J., Krieger M., Joiner K.A. The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc. Natl. Acad. USA. 91:1994;1863-1867.
22. Ember J.A., Jagels M.A., Hugli T.E. Volanakis J.E., Frank M.M. Characterization of Complement Anaphylatoxins and their Biological Responses. 1998;241-284 Marcel Dekker, New York.
23. Epstein J., Eichbaum Q., Sheriff S., Ezekowitz R.A. The collectins in innate immunity. Curr. Opin. Immunol. 8:1996;29-35.
24. Fallman M., Andersson R., Andersson T. Signaling properties of CR3 (CD11b/CD18) and CR1 (CD35) in relation to phagocytosis of complement-opsonized particles. J. Immunol. 151:1993;330-338.
25. Fang Y.F., Xu C.G., Fu Y.X., Holers V.M., Molina H. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 160:1998;5273-5279. June 1.
26. Fearon D.T. Seeking wisdom in innate immunity. Nature. 388:1997;323-324.
27. Fearon D.T., Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science. 272:1996;50-53.
28. Fischer M.B., Ma M., Goerg S., Zhou X., Xia J., Finco O., Han S., Kelsoe G., Howard R.G., Rothstein T.L., Kremmer E., Rosen F.S., Carroll M.C. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157:1996;549-556.
29. Fischer M.B., Prodeus A.P., Nicholson-Weller A., Ma M.H., Murrow J., Reid R.R., Warren H.B., Lage A.L., Moore F.D.J., Rosen F.S., Carroll M.C. Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. J. Immunol. 159:1997;976-982.
30. Fischer M.B., Goerg S., Shen L., Prodeus A.P., Goodnow C.C., Kelsoe G., Carroll M.C. Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science. 280:1998;582-585.
31. Flajnik M.F., Salter-Cid L. Evolution and developmental regulation of the major histocompatibility complex. Crit. Rev. Immunol. 15:1995;31-75.
32. Fodor W.L., Rollins S.A., Biancocaron S., Rother R.P., Guilmette E.R., Burton W.V., Albrecht J.C., Fleckenstein B., Squinto S.P. The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity. J. Virol. 69:1995;3889-3892.
33. Fujii T., Nakamura T., Sekizawa A., Tomonaga S. Isolation and characterization of a protein from hagfish serum that is homologous to the 3rd component of the mammalian complement system. J. Immunol. 148:1992;117-123.
34. Gewurz H., Zhang X.H., Lint T.F. Structure and function of the pentraxins. Curr. Opin. Immunol. 7:1995;54-64.
35. Gibson N.C., Waxman F.J. Relationship between immune complex binding and release and the quantitative expression of the complement receptor, type 1 (Cr1, Cd35) on human erythrocytes. Clin. Immunol. Immunopathol. 70:1994;104-113.
36. Gonzalez M.L., Waxman F.J. Glomerular deposition of immune complexes made with IgG2a monoclonal antibodies. J. Immunol. 164:2000;1071-1077.
37. Hasty L.A., Lessey B.A., Pruksananonda S., Lambris J.D., Lyttle C.R. The hormonal regulation of complement components throughout the menstrual cycle. Annual Meeting of the Society for Gynecologic Investigation. 1991.
38. Hoffmann J.A., Kafatos F.C., Janeway C.A., Ezekowitz R.A. Phylogenetic perspectives in innate immunity. Science. 284:1999;1313-1318.
39. Hourcade D., Holers V.M., Atkinson J.P. The regulators of complement activation (RCA) gene cluster. Adv. Immunol. 45:1989;381-416.
40. Iwata K., Seya T., Yanagi Y., Pesando J.M., Johnson P.M., Okabe M., Ueda S., Ariga H., Nagasawa S. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46. J. Biol. Chem. 270:1995;15148-15152.
41. Joiner K.A. Complement evasion by bacteria and parasites. Annu. Rev. Microbiol. 42:1988;201-230.
42. Kawasaki N., Kawasaki T., Yamashina I. Isolation and characterization of a mannan-binding protein from human serum. J. Biochem. (Tokyo). 94:1983;937-947.
43. Kopf M., Herren S., Wiles M.V., Pepys M.B., Kosco-Vilbois M.H. Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component. J. Exp. Med. 188:1998;1895-1906.
44. Kostavasil I., Sahu A., Friedman H.M., Eisenberg R.J., Cohen G.H., Lambris J.D. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus. J. Immunol. 158:1997;1763-1771.
45. Lambris J.D. The Third Component of Complement: Chemistry and Biology. 1990;Springer, Berlin.
46. Lambris J.D., Holers V.M. Therapeutic Interventions in the Complement System. 2000;Humana Press, Totawa, NJ, USA.
47. Lambris J.D., Mavroidis M., Sunyer J.O. Erdei A. Phylogeny of Third Component of Complement, C3. 1994;15-34 R.G. Landes, Austin.
48. Lambris J.D., Sahu A., Wetsel R. Volanakis J.E., Frank M. The Chemistry and Biology of C3, C4, and C5. 1998;83-118 Marcel Dekker, New York.
49. Litman G.W., Rast J.P. The organization and structure of immunoglobulin and T-cell receptor genes in the most phylogenetically distant jawed vertebrates: evolutionary implications. Res. Immunol. 147:1996;226-233.
50. Lubinski J., Wang L., Mastellos D., Sahu A., Lambris J.D., Friedman H.M. In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC. J. Exp. Med. 190:1999;1637-1646.
51. Magor K.E., Vasta G.R. Ancestral immunity comes of age. Immunol. Today. 19:1998;54-56.
52. Marchalonis J.J., Bernstein R.M., Shen S.X., Schluter S.F. Emergence of the immunoglobulin family. Conservation in protein sequence and plasticity in gene organization. Glycobiology. 6:1996;657-663.
53. Mastellos D., Papageorgiou J., Franchini S., Tsonis P.A., Lambris J.D. A role of complement component C5 in liver regeneration. Immunopharmacology. 2000;. in press.
54. Matsushita M. The lectin pathway of the complement system. Microbiol. Immunol. 40:1996;887-893.
55. Matsushita M., Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J. Exp. Med. 176:1992;1497-1502.
56. Matsushita M., Fujita T. Cleavage of the third component of complement (C3) by mannose-binding protein-associated serine protease (MASP) with subsequent complement activation. Immunobiology. 194:1995;443-448.
57. Matsushita M., Endo Y., Nonaka M., Fujita T. Complement-related serine proteases in tunicates and vertebrates. Curr. Opin. Immunol. 10:1998;29-35.
58. McNearney T.A., Odell C., Holers V.M., Spear P.G., Atkinson J.P. Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity. J. Exp. Med. 166:1987;1525-1535.
59. Medzhitov R., Janeway C.A. Jr. Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9:1997a;4-9.
60. Medzhitov R., Janeway C.A. Jr. Innate immunity: the virtues of a nonclonal system of recognition. Cell. 91:1997b;295-298.
61. Merino S., Camprubi S., Alberti S., Benedi V.J., Tomas J.M. Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing. Infect. Immun. 60:1992;2529-2535.
62. Molina H., Holers V.M., Li B., Fung Y., Mariathasan S., Goellner J.S.-S.J., Karr R.W., Chaplin D.D. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. U.S.A. 93:1996;3357-3361.
63. Morgan B.P., Harris C.L. Complement Regulatory Proteins. 1999;Academic Press.
64. Morgan B.P., Walport M.J. Complement deficiency and disease. Immunol. Today. 12:1991;301-306.
65. Nakao M., Mutsuro J., Obo R., Fujiki K., Nonaka M., Yano T. Molecular cloning and protein analysis of divergent forms of the complement component C3 from a bony fish, the common carp (Cyprinus carpio): presence of variants lacking the catalytic histidine. Eur. J. Immunol. 30:2000;858-866.
66. Nilsson G., Johnell M., Hammer C.H., Tiffany H.L., Nilsson K., Metcalfe D.D., Siegbahn A., Murphy P.M. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J. Immunol. 157:1996;1693-1698.
67. Nonaka M., Takahashi M. Complete complementary DNA sequence of the 3rd component of complement of Lamprey: implication for the evolution of thioester containing proteins. J. Immunol. 148:1992;3290-3295.
68. Nonaka M., Takahashi M., Sasaki M. Molecular cloning of a Lamprey homologue of the mammalian MHC class III gene, complement factor B. J. Immunol. 152:1994;2263-2269.
69. Nonaka M., Azumi K., Ji X., Namikawa-Yamada C., Sasaki M., Saiga H., Dodds A.W., Sekine H., Homma M.K., Matsushita M., Endo Y., Fujita T. Opsonic complement component C3 in the solitary ascidian, Halocynthia roretzi. J. Immunol. 162:1999;387-391.
70. Noorchashm H., Moore D.J., Lieu Y.K., Noorchashm N., Schlachterman A., Song H.K., Lambris J.D., Barker C.F., Naji A. Contribution of the innate immune system to autoimmune diabetes: a role for the CR1/CR2 complement receptors. Cell. Immunol. 195:(1):1999;75-79.
71. Pasinetti G.M., Tocco G., Sakhi S., Musleh W.D., DeSimoni M.G., Mascarucci P., Schreiber S., Baudry M., Finch C.E. Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions. Neurobiol. Dis. 3:1996;197-204.
72. Prada A.E., Zahedi K., Davis A.E. III. Regulation of C1 inhibitor synthesis. Immunobiology. 199:1998;377-388.
73. Prodeus A.P., Zhou X., Maurer M., Galli S.J., Carroll M.C. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature. 390:1997;172-175.
74. Puentes S.M., Dasilva R.P., Sacks D.L., Hammer C.H., Joiner K.A. Serum resistance of metacyclic stage leishmania-major promastigotes is due to release of C5b-9. J. Immunol. 145:1990;4311-4316.
75. Rast J.P., Litman G.W. T-cell receptor gene homologs are present in the most primitive jawed vertebrates. Proc. Natl. Acad. Sci. U.S.A. 91:1994;9248-9252.
76. Ratcliffe N.A., Leonard C., Rowley A.F. Prophenoloxidase activation, non-self recognition and cell co-operation in insect immunity. Science. 226:1984;557-559.
77. Reid R.R., Prodeus A.P., Khan W., Hsu T., Rosen F.S., Carroll M.C. Endotoxin shock in antibody-deficient mice - unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. J. Immunol. 159:1997;970-975. July 15.
78. Reid K.B., Colomb M.G., Loos M. Complement component C1 and the collectins: parallels between routes of acquired and innate immunity. Immunol. Today. 19:1998;56-59.
79. Rosse W.F., Parker C.J. Paroxysmal nocturnal haemoglobinuria. Clin. Haematol. 14:1985;105-125.
80. Russo J.J., Bohenzky R.A., Chien M.C., Chen J., Yan M., Maddalena D., Parry J.P., Peruzzi D., Edelman I.S., Chang Y., Moore P.S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA. 93:1996;14862-14867.
81. Sahu A., Isaacs S.N., Soulika A.M., Lambris J.D. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b(1) inactivates the alternative complement pathway. J. Immunol. 160:1998;5596-5604.
82. Saifuddin M., Hedayati T., Atkinson J.P., Holguin M.H., Parker C.J., Spear G.T. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. J. Gen. Virol. 78:1997;1907-1911. (Part 8).
83. Simpson K.L., Holmes C.H. Differential expression of complement regulatory proteins decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 during human spermatogenesis. Immunology. 81:1994;452-461.
84. Smith L.C., Shih C.S., Dachenhausen S.G. Coelomocytes express SpBf, a homologue of factor B, the second component in the sea urchin complement system. J. Immunol. 161:1998;6784-6793.
85. Stahl P.D., Ezekowitz R.A. The mannose receptor is a pattern recognition receptor involved in host defense. Curr. Opin. Immunol. 10:1998;50-55.
86. Stoiber H., Clivio A., Dierich M.P. Role of complement in HIV infection. Annu. Rev. Immunol. 15:1997;649-674.
87. Suankratay C., Mold C., Zhang Y., Potempa L.A., Lint T.F., Gewurz H. Complement regulation in innate immunity and the acute-phase response: inhibition of mannan-binding lectin-initiated complement cytolysis by C-reactive protein (CRP). Clin. Exp. Immunol. 113:1998;353-359.
88. Sun X., Funk C.D., Deng C., Sahu A., Lambris J.D., Song W.C. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting. Proc. Natl. Acad. Sci. U.S.A. 96:1999;628-633.
89. Sundstrom S.A., Komm B.S., Ponce-de-Leon H., Yi Z., Teuscher C., Lyttle R.C. Estrogen regulation of tissue-specific expression of complement C3. J. Biol. Chem. 264:(28):1989;16941-16947.
90. Sunyer J.O., Lambris J.D. Evolution and diversity of the complement system of poikilothermic vertebrates. Immunol. Rev. 166:1998;39-57.
91. Sunyer J.O., Tort L. Natural haemolytic and bactericidal activities of sea bream (Sparus aurata) are effected by the alternative complement pathway. Vet. Immunol. Immunopathol. 45:1995;333-345.
92. Sunyer J.O., Zarkadis I.K., Sahu A., Lambris J.D. Multiple forms of complement C3 in trout, that differ in binding to complement activators. Proc. Natl. Acad. Sci. U.S.A. 93:1996;8546-8551.
93. Sunyer J.O., Tort L., Lambris J.D. Structural C3 diversity in fish - characterization of five forms of C3 in the diploid fish Sparus aurata. J. Immunol. 158:1997a;2813-2821.
94. Sunyer J.O., Tort L., Lambris J.D. Diversity of the third form of complement, C3, in fish: functional characterization of five forms of C3 in the diploid fish Sparus aurata. Biochem. J. 326:1997b;877-881.
95. Sunyer J.O., Zarkadis I.K., Lambris J.D. Complement diversity: a mechanism for generating immune diversity? Immunol. Today. 19:1998;519-523.
96. Szalai A.J., Agrawal A., Greenhough T.J., Volanakis J.E. C-reactive protein: structural biology, gene expression, and host defense function. Immunol. Res. 16:1997;127-136.
97. Thiel S., Holmskov U., Hviid L., Laursen S.B., Jensenius J.C. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin. Exp. Immunol. 90:1992;31-35.
98. Thiel S., Vorup-Jensen T., Stover C.M., Schwaeble W., Laursen S.B., Poulsen K., Willis A.C., Eggleton P., Hansen S., Holmskov U., Reid K.B., Jensenius J.C. A second serine protease associated with mannan-binding lectin that activates complement. Nature. 386:1997;506-510. April 3.
99. Tooze R.M., Doody G.M., Fearon D.T. Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin. Immunity. 7:1997;59-67.
100. Tsokos G.C., Lambris J.D., Finkelman F.D., Anastassiou E.D., June C.H. Monovalent ligands of complement receptor 2 inhibit whereas polyvalent ligands enhance anti-Ig-induced human B cell intracytoplasmic free calcium concentration. J. Immunol. 144:1990;1640-1645.
101. Tsoukas C.D., Lambris J.D. Expression of EBV/C3d receptors on T cells: biological significance. Immunol. Today. 14:1993;56-59.
102. Turner M.W. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol. Today. 17:1996;532-540.
103. Ulevitch R.J., Tobias P.S. Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr. Opin. Immunol. 11:1999;19-22.
104. van den Dobbelsteen M.E., Verhasselt V., Kaashoek J.G., Timmerman J.J., Schroeijers W.E., Verweij C.L., van der Woude F.J., van Es L.A., Daha M.R. Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gamma. Clin. Exp. Immunol. 95:1994;173-180.
105. Vanderplasschen A., Mathew E., Hollinshead M., Sim R.B., Smith G.L. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc. Natl. Acad. Sci. U.S.A. 95:1998;7544-7549.
106. Vasta G.R., Ahmed A., Fink N.E., Elola M.T., Marsh A.G., Snowden A., Odom E.W. Animal lectins as self/non-self recognition molecules-biochemical and genetic approaches to understanding their biological roles and evolution. Ann. N. Y. Acad. Sci. 1994;55-73. New York.
107. Volanakis J.E., Frank M. The Human Complement System in Health and Disease. 1998;Marcel Dekker, New York, NY.
108. Warr G.W. The immunoglobulin genes of fish. Dev. Comp. Immunol. 19:1995;1-12.
109. Weiser M.R., Williams J.P., Moore F.D., Kobzik L., Ma M.H., Hechtman H.B., Carroll M.C. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J. Exp. Med. 183:1996;2343-2348.
110. Wetsel R.A. Structure, function and cellular expression of complement anaphylatoxin receptors. Curr. Opin. Immunol. 7:1995;48-53.
111. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1990;1431-1433. [see comments].
112. Xia Y., Ross G.D. Roles of integrins CR3 and CR4 in disease and therapeutic strategies. Lambris J.D., Holers V.M. Therapeutic Interventions in the Complement System. 2000;Humana Press, Totawa, NJ, USA.
113. Xu C., Mao D., Holers V.M., Palanca B., Cheng A.M., Molina H. A critical role for murine complement regulator crry in fetomaternal tolerance. Science. 287:2000;498-501.
114. Yamashina M., Ueda E., Kinoshita T., Takami T., Ojima A., Ono H., Tanaka H., Kondo N., Orii T., Okada N. Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. N. Engl. J. Med. 323:1990;1184-1189.
115. Yokoyama I., Waxman F. Isotypic and clonal variations in the interactions between model monoclonal immune complexes and the human erythrocyte CR1-receptor. Mol. Immunol. 29:1992;935-947.